N
ACLX

Natixis’s Arcellx ACLX Stock Holding History

Natixis’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-80
Closed -$5.27K – 1060
2025
Q2 		$5.27K Buy
+80
New +$4.98K ﹤0.01% 967

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Natixis's ACLX Position: Q3 2025 in Review

Natixis sold out of Arcellx (ACLX) in Q3 2025, closing a stake of 80 shares — an estimated $5.27K sold.

Natixis first reported a position in ACLX in Q2 2025 and held it in 1 quarter. The position peaked at $5.27K in Q2 2025. 209 funds tracked by Wall St. Rank hold ACLX as of Q3 2025.

  • Natixis reported no remaining Arcellx position as of Q3 2025 after selling out during the quarter.
  • Natixis sold 80 Arcellx shares in Q3 2025, an estimated $5.27K.
  • Natixis first reported a position in Arcellx in Q2 2025 and held it in 1 quarter.
  • Natixis's Arcellx position peaked at $5.27K in Q2 2025.
  • 209 funds tracked by Wall St. Rank held Arcellx as of Q3 2025.

Based on Natixis's 13F filing for Q3 2025, filed 14 Nov 2025.